Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SZMUNESS, W.
Right arrow Articles by PRINCE, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SZMUNESS, W.
Right arrow Articles by PRINCE, A. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 92, No. 1: 51-61
Copyright © 1970 by The Johns Hopkins University School of Hygiene and Public Health


other

THE SERUM HEPATITIS VIRUS SPECIFIC ANTIGEN (SH): A PRELIMINARY REPORT OF EPIDEMIOLOGIC STUDIES IN AN INSTITUTION FOR THE MENTALLY RETARDED1

WOLF SZMUNESS, RUBIN PICK and ALFRED M. PRINCE

Szmuness, W. (New York Blood Center, 310 E. 67th St., N. Y., N. Y. 10021), R. Pick and A. M. Prince. The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded. Amer. J. Epid., 1970, 92: 51–61.-SH antigen was detected in 35.1% of patients with Down's syndrome and in 17.2% of a matched sample of patients with other forms of mental retardation. One-half of the antigen carriers had biochemical signs of chronic active anicteric hepatitis. The duration of the carrier state appears to be longer in Down's syndrome patients. Statistical associations between the occurrence of the carrier state and different risk factors have been established. Among these, age at the time of exposure appeared to be the most important. Certain epidemiologic conditions peculiar to this population appear to favor nonparenteral transmission of SH virus(s). Due to limitations in sample size and design of the study, these hypotheses require further evaluation in other populations.

Australia/SH antigen; carrier state; Down's syndrome; epidemiology; hepatitis, chronic; mental retardation; serum hepatitis; virology


1From the New York Blood Center, The New York Hospital-Cornell Medical Center, New York, N. Y., and Suffolk State School, Long Island, N. Y. This study was supported by NIH grants #TI AM 6430 and HE 09011 and a grant-in-aid from The Strasburger Foundation. A. M. Prince is the recipient of a Career Scientist Award of the Health Research Council of the City of New York under Contract #1–533.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.